The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.o

Neutrophilic dermatosis (Pyoderma, Sweet syndrome)

Publications

Ozlem C, Deram B, Mustafa S, Koray T, Cuyan D, Ertugrul T

Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease.

Internal medicine (Tokyo, Japan) 2011;50;1973-6 — 2011 — 1973-6

Hasegawa M, Sato S, Nakada M, Nitta H, Shirasaki H, Kasahara K, Takehara K

Sweet's syndrome associated with granulocyte colony-stimulating factor.

European journal of dermatology : EJD 1998 Oct-Nov;8;503-5 — 1998 Oct-Nov — 503-5

Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP

The Sweet syndrome during therapy with granulocyte colony-stimulating factor.

Annals of internal medicine 1992 Jun 15;116;996-8 — 1992 Jun 15 — 996-8